carnitine has been researched along with Acute Kidney Failure in 27 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "This controlled pilot cohort study of 48 children investigated effects of levocarnitine supplementation on myocardial strain in children receiving CKRT for acute kidney injury (AKI)." | 8.02 | Effect of levocarnitine supplementation on myocardial strain in children with acute kidney injury receiving continuous kidney replacement therapy: a pilot study. ( Clauss, S; Moudgil, A; Sgambat, K, 2021) |
| "Cimetidine treatment significantly decreased creatinine, BUN, K, Na, SBP and creatine kinase and increased GFR and urine volume compared to group II." | 5.42 | A study on the effect of cimetidine and L-carnitine on myoglobinuric acute kidney injury in male rats. ( Eissa, H; Elattar, S; Estaphan, S; Farouk, M; Rashed, L, 2015) |
| "Treatment of L-carnitine 30 min prior to reperfusion significantly relieved I/R-induced metabolomic changes." | 5.38 | Metabolomic changes and protective effect of (L)-carnitine in rat kidney ischemia/reperfusion injury. ( Dai, W; Hu, W; Ji, C; Liu, Y; Mei, C; Yan, S; Zhang, W, 2012) |
| "This controlled pilot cohort study of 48 children investigated effects of levocarnitine supplementation on myocardial strain in children receiving CKRT for acute kidney injury (AKI)." | 4.02 | Effect of levocarnitine supplementation on myocardial strain in children with acute kidney injury receiving continuous kidney replacement therapy: a pilot study. ( Clauss, S; Moudgil, A; Sgambat, K, 2021) |
| "It has been found that L-carnitine ameliorated cisplatin-induced acute kidney injury (AKI) in rats." | 3.85 | L-Carnitine Ameliorates the Decrease of Aquaporin 2 Levels in Rats with Cisplatin-Induced Kidney Injury. ( Gao, J; Gao, Y; Gu, Z; Li, M; Liang, B; Na, Y; Wei, J; Xu, Y, 2017) |
| "We have previously shown that carboplatin induces inflammation and apoptosis in renal tubular cells (RTCs) through the activation of the nuclear factor of activated T cells-3 (NFAT3) protein by reactive oxygen species (ROS), and that the ROS-mediated activation of NFAT3 is prevented by N-acetyl cysteine and heme oxygenase-1 treatment." | 3.80 | L-carnitine protects against carboplatin-mediated renal injury: AMPK- and PPARα-dependent inactivation of NFAT3. ( Chang, CC; Chou, HC; Chou, Y; Juan, SH; Sue, YM; Yang, NJ, 2014) |
| "Phenazopyridine (Pyridium) is a commonly used urinary tract analgesic." | 2.43 | Acute renal failure due to phenazopyridine (Pyridium) overdose: case report and review of the literature. ( Abitbol, C; Berho, ME; Chandar, J; Espinoza, V; Onder, AM; Zilleruelo, G, 2006) |
| "L-carnitine or furosemide was administered, and serial blood samples were collected and analyzed to assess the effects of hydronephrosis on the pharmacokinetic parameters." | 1.56 | Rats with congenital hydronephrosis show increased susceptibility to renal ischemia-reperfusion injury. ( Cirule, H; Dambrova, M; Liepinsh, E; Sevostjanovs, E; Videja, M; Vilks, K; Vilskersts, R; Zharkova-Malkova, O, 2020) |
| "Cimetidine treatment significantly decreased creatinine, BUN, K, Na, SBP and creatine kinase and increased GFR and urine volume compared to group II." | 1.42 | A study on the effect of cimetidine and L-carnitine on myoglobinuric acute kidney injury in male rats. ( Eissa, H; Elattar, S; Estaphan, S; Farouk, M; Rashed, L, 2015) |
| "Treatment of L-carnitine 30 min prior to reperfusion significantly relieved I/R-induced metabolomic changes." | 1.38 | Metabolomic changes and protective effect of (L)-carnitine in rat kidney ischemia/reperfusion injury. ( Dai, W; Hu, W; Ji, C; Liu, Y; Mei, C; Yan, S; Zhang, W, 2012) |
| "Hypoparathyroidism has been previously reported in some MFAO deficiencies but has never been mentioned in association with MCADD." | 1.35 | Hypoketotic hypoglycemia with myolysis and hypoparathyroidism: an unusual association in medium chain acyl-CoA desydrogenase deficiency (MCADD). ( Baruteau, J; Bloom, MC; Broué, P; Levade, T; Mesli, S; Redonnet-Vernhet, I, 2009) |
| " The recommended dosage of clofibrate is 1." | 1.26 | [Fat and renal failure--therapeutic aspects]. ( Heidland, A; Hörl, M; Hörl, WH, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (22.22) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (18.52) | 29.6817 |
| 2010's | 13 (48.15) | 24.3611 |
| 2020's | 3 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Sabry, MM | 1 |
| Ahmed, MM | 1 |
| Maksoud, OMA | 1 |
| Rashed, L | 2 |
| Morcos, MA | 1 |
| El-Maaty, AA | 1 |
| Maher Galal, A | 1 |
| Sharawy, N | 1 |
| Vilskersts, R | 1 |
| Vilks, K | 1 |
| Videja, M | 1 |
| Cirule, H | 1 |
| Zharkova-Malkova, O | 1 |
| Sevostjanovs, E | 1 |
| Dambrova, M | 1 |
| Liepinsh, E | 1 |
| Sgambat, K | 2 |
| Clauss, S | 1 |
| Moudgil, A | 2 |
| Dastan, F | 1 |
| Talasaz, AH | 1 |
| Mojtahedzadeh, M | 1 |
| Karimi, A | 1 |
| Salehiomran, A | 1 |
| Bina, P | 1 |
| Jalali, A | 1 |
| Alabi, QK | 1 |
| Akomolafe, RO | 1 |
| Olukiran, OS | 1 |
| Nafiu, AO | 1 |
| Adefisayo, MA | 1 |
| Owotomo, OI | 1 |
| Omole, JG | 1 |
| Olamilosoye, KP | 1 |
| Wan, X | 1 |
| Li, X | 1 |
| Wang, Q | 1 |
| Zheng, B | 1 |
| Zhou, C | 1 |
| Kang, X | 1 |
| Hu, D | 1 |
| Bao, H | 1 |
| Peng, A | 1 |
| Sue, YM | 1 |
| Chou, HC | 1 |
| Chang, CC | 1 |
| Yang, NJ | 1 |
| Chou, Y | 1 |
| Juan, SH | 1 |
| Estaphan, S | 1 |
| Eissa, H | 1 |
| Elattar, S | 1 |
| Farouk, M | 1 |
| Gao, J | 1 |
| Gu, Z | 1 |
| Li, M | 1 |
| Xu, Y | 1 |
| Gao, Y | 1 |
| Wei, J | 1 |
| Liang, B | 1 |
| Na, Y | 1 |
| Ustundag, S | 1 |
| Sen, S | 1 |
| Yalcin, O | 1 |
| Ciftci, S | 1 |
| Demirkan, B | 1 |
| Ture, M | 1 |
| Al-Shabanah, OA | 1 |
| Aleisa, AM | 1 |
| Al-Yahya, AA | 1 |
| Al-Rejaie, SS | 1 |
| Bakheet, SA | 1 |
| Fatani, AG | 1 |
| Sayed-Ahmed, MM | 1 |
| Baruteau, J | 1 |
| Levade, T | 1 |
| Redonnet-Vernhet, I | 1 |
| Mesli, S | 1 |
| Bloom, MC | 1 |
| Broué, P | 1 |
| Uzunoglu, S | 1 |
| Karagol, H | 1 |
| Ozpuyan, F | 1 |
| Cosar, R | 1 |
| Cicin, I | 1 |
| Yurutcaloglu, V | 1 |
| Denizli, B | 1 |
| Tanriverdi, Ö | 1 |
| Sut, N | 1 |
| Kocak, Z | 1 |
| Yuksel, S | 1 |
| Sezer, MT | 1 |
| Sahin, O | 1 |
| Sutcu, R | 1 |
| Koçogullari, C | 1 |
| Yilmaz, HR | 1 |
| Uz, E | 1 |
| Kara, Y | 1 |
| Aydin, B | 1 |
| Altuntas, A | 1 |
| Savranlar, Y | 1 |
| Sönmez, MF | 1 |
| Sun, J | 1 |
| Shannon, M | 1 |
| Ando, Y | 1 |
| Schnackenberg, LK | 1 |
| Khan, NA | 1 |
| Portilla, D | 1 |
| Beger, RD | 1 |
| Liu, Y | 1 |
| Yan, S | 1 |
| Ji, C | 1 |
| Dai, W | 1 |
| Hu, W | 1 |
| Zhang, W | 1 |
| Mei, C | 1 |
| Enomoto, A | 1 |
| Endou, H | 1 |
| Onder, AM | 1 |
| Espinoza, V | 1 |
| Berho, ME | 1 |
| Chandar, J | 1 |
| Zilleruelo, G | 1 |
| Abitbol, C | 1 |
| Sharma, AP | 1 |
| Greenberg, CR | 1 |
| Prasad, AN | 1 |
| Prasad, C | 1 |
| Druml, W | 1 |
| Laggner, A | 1 |
| Lenz, K | 1 |
| Balcke, P | 1 |
| Kleinberger, G | 1 |
| Schmidt, P | 1 |
| Hörl, WH | 3 |
| Hörl, M | 1 |
| Heidland, A | 1 |
| Bank, WJ | 1 |
| DiMauro, S | 1 |
| Bonilla, E | 1 |
| Capuzzi, DM | 1 |
| Rowland, LP | 1 |
| Wanner, C | 2 |
| Riegel, W | 1 |
| Schaefer, RM | 1 |
| Guarnieri, G | 1 |
| Toigo, G | 1 |
| Crapesi, L | 1 |
| Situlin, R | 1 |
| Del Bianco, MA | 1 |
| Corsi, M | 1 |
| LoGreco, P | 1 |
| Paviotti, G | 1 |
| Mioni, G | 1 |
| Campanacci, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pilot Study: Effect of Carnitine Supplementation on Acylcarnitine Profile and Myocardial Function in Children and Young Adults Receiving Continuous Renal Replacement Therapy[NCT01941823] | 29 participants (Actual) | Observational | 2014-12-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for carnitine and Acute Kidney Failure
| Article | Year |
|---|---|
Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease.
Topics: Acute Kidney Injury; Animals; Carnitine; Carrier Proteins; Free Radical Scavengers; Humans; Kidney F | 2005 |
Acute renal failure due to phenazopyridine (Pyridium) overdose: case report and review of the literature.
Topics: Acetylcysteine; Acute Kidney Injury; Adolescent; Carnitine; Female; HIV Infections; Humans; Infectio | 2006 |
Carnitine abnormalities in patients with renal insufficiency. Pathophysiological and therapeutical aspects.
Topics: Acute Kidney Injury; Carnitine; Humans; Kidney Diseases; Kidney Failure, Chronic; Renal Dialysis | 1988 |
Carnitine metabolism in chronic renal failure.
Topics: Acetates; Acute Kidney Injury; Carnitine; Humans; Renal Dialysis; Uremia | 1987 |
1 trial available for carnitine and Acute Kidney Failure
| Article | Year |
|---|---|
Randomized Trial of Carnitine for the Prevention of Perioperative Atrial Fibrillation.
Topics: Acute Kidney Injury; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Biomarkers; C-Reactive Prote | 2018 |
22 other studies available for carnitine and Acute Kidney Failure
| Article | Year |
|---|---|
Carnitine, apelin and resveratrol regulate mitochondrial quality control (QC) related proteins and ameliorate acute kidney injury: role of hydrogen peroxide.
Topics: Acute Kidney Injury; Adenosine Triphosphatases; Adenosine Triphosphate; Angiotensins; Animals; Antio | 2022 |
Rats with congenital hydronephrosis show increased susceptibility to renal ischemia-reperfusion injury.
Topics: Acute Kidney Injury; Animals; Carnitine; Cell Adhesion Molecules; Disease Susceptibility; Diuretics; | 2020 |
Effect of levocarnitine supplementation on myocardial strain in children with acute kidney injury receiving continuous kidney replacement therapy: a pilot study.
Topics: Acute Kidney Injury; Carnitine; Child; Continuous Renal Replacement Therapy; Dietary Supplements; Hu | 2021 |
Combined Administration of l-Carnitine and Ascorbic Acid Ameliorates Cisplatin-Induced Nephrotoxicity in Rats.
Topics: Acute Kidney Injury; Animals; Antioxidants; Ascorbic Acid; Biomarkers; Body Weight; Carnitine; Cispl | 2018 |
Metabolitic profiling of amino acids in paraquat-induced acute kidney injury.
Topics: Acute Kidney Injury; Adult; Amino Acids; Area Under Curve; Biomarkers; Carnitine; Case-Control Studi | 2019 |
L-carnitine protects against carboplatin-mediated renal injury: AMPK- and PPARα-dependent inactivation of NFAT3.
Topics: Acute Kidney Injury; AMP-Activated Protein Kinases; Animals; Apoptosis; Carboplatin; Carnitine; Cycl | 2014 |
A study on the effect of cimetidine and L-carnitine on myoglobinuric acute kidney injury in male rats.
Topics: Acute Kidney Injury; Animals; Carnitine; Cimetidine; Creatine Kinase; Creatinine; Disease Models, An | 2015 |
Carnitine deficiency in children receiving continuous renal replacement therapy.
Topics: Acute Kidney Injury; Adolescent; Adult; Cardiomyopathies; Carnitine; Child; Child, Preschool; Female | 2016 |
L-Carnitine Ameliorates the Decrease of Aquaporin 2 Levels in Rats with Cisplatin-Induced Kidney Injury.
Topics: Acute Kidney Injury; Adenylyl Cyclases; Animals; Aquaporin 2; Arginine Vasopressin; Carnitine; Cispl | 2017 |
L-Carnitine ameliorates glycerol-induced myoglobinuric acute renal failure in rats.
Topics: Acute Kidney Injury; Animals; Carnitine; Glycerol; Kidney; Male; Malondialdehyde; Myoglobinuria; Oxi | 2009 |
Increased urinary losses of carnitine and decreased intramitochondrial coenzyme A in gentamicin-induced acute renal failure in rats.
Topics: Acute Kidney Injury; Adenosine Triphosphate; Animals; Blood Urea Nitrogen; Carnitine; Coenzyme A; Cr | 2010 |
Hypoketotic hypoglycemia with myolysis and hypoparathyroidism: an unusual association in medium chain acyl-CoA desydrogenase deficiency (MCADD).
Topics: Acute Kidney Injury; Acyl-CoA Dehydrogenase; Carnitine; Child, Preschool; Female; Glucose; Humans; H | 2009 |
Protective effect of L-carnitine versus amifostine against cisplatin-induced nephrotoxicity in rats.
Topics: Acute Kidney Injury; Amifostine; Animals; Antineoplastic Agents; Carnitine; Cisplatin; Male; Rats; R | 2011 |
The role of carnitine in preventing renal damage developed as a result of infrarenal aortic ischemia-reperfusion.
Topics: Acute Kidney Injury; Animals; Aorta, Abdominal; Carnitine; Kidney; Male; Random Allocation; Rats; Ra | 2011 |
Letter to the editor regarding the article by Uzunoglu et al.
Topics: Acute Kidney Injury; Amifostine; Animals; Carnitine; Cisplatin; Male | 2012 |
Serum metabolomic profiles from patients with acute kidney injury: a pilot study.
Topics: Acute Kidney Injury; Adult; Amino Acids; Biomarkers; Carnitine; Case-Control Studies; Chromatography | 2012 |
Metabolomic changes and protective effect of (L)-carnitine in rat kidney ischemia/reperfusion injury.
Topics: Acute Kidney Injury; Animals; Carnitine; Disease Models, Animal; Energy Metabolism; Male; Malondiald | 2012 |
Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder.
Topics: Acute Kidney Injury; Betaine; Brain Diseases, Metabolic, Inborn; Carnitine; Carrier Proteins; Combin | 2007 |
[Lipid metabolism and lipid utilization in renal failure].
Topics: Acute Kidney Injury; Carnitine; Cholesterol; Energy Metabolism; Fat Emulsions, Intravenous; Humans; | 1983 |
[Fat and renal failure--therapeutic aspects].
Topics: Acute Kidney Injury; Animals; Bezafibrate; Carnitine; Charcoal; Clofibrate; Clofibric Acid; Humans; | 1982 |
A disorder of muscle lipid metabolism and myoglobinuria. Absence of carnitine palmityl transferase.
Topics: Acute Kidney Injury; Acyltransferases; Adolescent; Adult; Carnitine; Cholesterol; Creatine Kinase; F | 1975 |
Carnitine and carnitine esters in acute renal failure.
Topics: Acute Kidney Injury; Animals; Carnitine; Esters; Female; Humans; Kidney; Liver; Male; Muscles; Rats; | 1989 |